INTRODUCTION
Based on considerations of molecular structure, a nomenclature has been proposed for three classes of toxin, namely, simple toxin, syntoxin, and mixtoxin (6, 8) . Simple toxin was defined as a monomer or polymer of a toxic simple protein, the term simple protein being employed in its traditional meaning of a protein composed exclusively of amino acids. Newer knowledge has now demonstrated a need to expand this definition of a simple toxin to include all the possible kinds of toxic simple proteins distinguishable from the syntoxins and mixtoxins. In what follows we hope to make this need clear. Also, we will suggest means for resolution of the nomenclatural problems raised by the situation for the botulinal toxins.
A simple toxin is characterizable biophysically as a molecular species which possesses distinctive properties as a poison. As defined by Bonventre, Lincoln, and Lamanna (8) , a simple toxin may be a toxic monomer capable of polymerization without loss of toxicity. It is also conceivable that the biological activity of a toxic monomer can be masked or abolished by polymerization, a situation now believed to exist for the staphylococcal alpha toxin (3) . This staphylococcal protein exists as a toxic molecule with a sedimentation value of 3S which shows evidence for reversible polymerization to form a biologically inert 12S molecule.
In contrast to the case for staphylococcal toxin, the potency of diptherial and tetanal toxins do not appear to vary in accordance with the state of association of a monomer. Subunits of diptherial toxin can be obtained by reduction of a larger-sized molecule, but these products have not been isolated in pure form to show their identity to monomers (12, 20) .
Recent work shows the diptherial toxin to be a 62,000-dalton single-chain polypeptide appar-F ently located in the cytoplasmic membrane. Upon the splitting of both a peptide and disulfide bond, it yields 24,000-and 38,000-dalton fragments (13, 20) . These fragments alone are not toxic for either the guinea pig or mammalian cell cultures.
Newest evidence on the nature of the tetanal toxin is that it is a simple protein of about 150,000 daltons with a sedimentation coefficient of 7S (4, 5, 26) . Although the molecule might eventually be proven to be made up of several polypeptide chains, it does not occur as a polymer of a monomer.
The botulinal toxins reveal still another kind of structure, namely the coexistence of different simple protein entities within a complex, only one of which is toxic, and held together by bonds easily broken by physical forces. Chromatographic separation (14, 17) and selective adsorption and elution from red-blood corpuscles (34) succeed in increasing the toxic potency of purified and crystalline botulinal toxins by separation of a nontoxic entity. This result is inconsistent with the thought that one is dealing with a polymer.
The characteristic quality of a polymer is that it is composed of repeating units of a single molecular species. Thus, the synthesis of a polymer is the bringing into association of a group of identical molecules. simple toxins will provide the factual basis for recommendations regarding nomenclature.
Crystalline type A botulinal toxin is a simple protein with a molecular weight of 900,000 daltons. It has been shown to be separable into two protein components, one with neurotoxic activity and the other a nontoxic hemagglutinin (15, 31, 34) . The two components can be separated and isolated by chromatography on diethylaminoethyl (DEAE)-Sephadex columns and differ antigenically. In isolation, the hemagglutinin component has a tendency toward self association (34) . The toxic component with a molecular weight of 150,000 has been labeled Aa and the atoxic component A13 by Das Gupta, Boroff, and Rothstein (15) . Upon treatment with various proteolytic enzymes, the crystalline toxin loses toxicity, whereas its hemagglutinating activity is not lost at all or lost more slowly (34) . This dissimilarity in sensitivity to proteolytic enzyme is further evidence for the existence of structural differences in these components of the crystalline toxin. It is evident that the hemagglutinin and toxin components form a stable crystallizable complex which possesses biophysical characteristics of a homogenous protein.
When isolated by DEAE-Sephadex chromatography, the type B toxin has been shown to exist as a protein molecule of more than 100,000 daltons (9) . The exact molecular dimension is said to be 165,000. Yet, as it exists in the culture medium before chromatography (42) 35, 1971 material (9; Schantz and Spero, p2rsonal communication). Type B material supplied to other investigators by Gerwing was not found to be homogeneous in Ouchterlony gel double-diffusion antigen-antibody tests, and, upon being rechromatographed, it yielded a toxic peak resembling 150,000-dalton material (9) . Obviously, contamination of the low-molecular-weight material isolated by Gerwing with large-size toxin has not been excluded and could account for the low toxicity of the material.
Both the 350,000 (S20w 11.6) and 150,000 (S20w 7.3) molecular weight E toxins have the interesting property of increase in biological activity after short-term exposure to trypsin. Exactly what happens to these molecules during exposure to the enzyme to cause the increase in toxicity is not known. The increase in toxicity is not accompanied by a decrease in S2ow value (28, 39) nor any change in the highest dilution of toxin capable of yielding immune precipitate lines (43) . Prolonged exposure to trypsin results in loss of toxicity (18, 39) . It is reasonable to explain these results by assuming that the initial action of trypsin is to break bonds, with the result of a minor change in the shape of the toxin molecule, which either makes it easier for the molecule to penetrate barriers to target sites or increases the exposure to toxophoric groupings of amino acids. Such a change in configuration might also lead to a better fit of the whole toxin molecule on the target substrate in the nervous system.
The concept of the whole protein molecule participating in fitting the configuration of a substrate is made legitimate by the findings with lysozyme. For this enzyme, Chipman and Sharon (10) discovered a cleft running the whole length of the molecule along which the substrate fits. This cleft exists in addition to localized groupings of specific amino acids as active sites for catalytic functioning.
There are reports of increases in toxicity by exposure of impure preparations of types A (7), B (7, 27) , and F (25) toxic material to trypsin.
Unlike the case for type E toxin, the products obtained from A, B, and F materials have not been purified and studied to learn whether they have a greater potency than toxin purified without exposure to trypsin. Thus it is not justified, on the basis of available data, to say that these reported activations of A, B, and F toxins yield a toxic molecule of increased specific activity. Other explanations are possible and must be excluded.
It should be realized that a trypsin-treated preparation of an impure toxin can show an increase in toxicity for any of four reasons: (i) conversion of nontoxic protein to toxic protein; (ii) No proven example is known of activation of botulinal toxin involving a splitting off of amino acids from a molecule. This mechanism has been assumed for the tryptic activation of type E toxin by Gerwing et al. (19) to explain their isolation of low-molecular-weight toxic material. Unfortunately, as already mentioned, other workers have not been able to confirm this claim of isolation of low-molecular-weight toxin (29) .
The generation of biological activity by limited enzymatic proteolysis is a well-known phenomenon in enzymology (36) . The first reported instance of an enzymatically induced increase in biological activity of a tissue-damaging substance of bacterial origin was probably for pneumococcal hemolysin (11) . Bacteriological examples of proteolytic enzyme activation of a substrate from a state of inactivity to activity are the epsilon (44) and iota (38) toxins of type D Clostridium perfringens and the toxin of Bacillus thuringiensis (2). The latter is parasporal crystalline protein which, although harmless by parenteral exposure, kills susceptible insects when ingested. The intramolecular changes accompanying these activations of bacterial toxins remain to be elucidated.
In 35, 1971 on October 16, 2017 by guest http://mmbr.asm.org/ Downloaded from "prototoxin," since, in their view, these terms imply a change from a state of biological inactivity to one of activity. For the sake of the historical record, it should be noted that, prior to the case of botulinal toxins, the term prototoxin had usage to identify proteolytic enzyme activation of toxicity in the case of epsilon (44) (1) .
Derivative toxin is a general term suited to label any toxic product, irrespective of the nature of the process separating it from its progenitor or a protoxin. The toxic products of activation and enhancement are included within this definition of derivative toxin. The use of the terms progenitor and derivative toxin has the virtue of elimination of any need for the alpha and beta designations for the toxic and nontoxic components of botulinal toxin suggested by Das Gupta et al. (15) . This is desirable because the Greek letter system has had prior usage for naming independently acting toxins produced by the same organism as well as the different antigenic types of botulinal toxin (6) .
To call a form of toxin primordial or a progenitor may imply a natural state, the state in which the toxin first appears in real life as an identifiable entity. On the other hand, one can visualize situations where progenitor material does not occur in nature. The label "progenitor" might be legitimately placed on a material either one or several steps removed from a naturally occurring source. Consequently, it is desirable to have a term which unequivocally identifies a toxic protein existent in nature. The etymologically legitimate word we propose for this purpose is "naturatoxin." At the present time, knowledge is not available to make unequivocal choices in deciding the origin of known toxic proteins as between their synthesis from amino acids as the immediate phenotypic expression of the genetic code or derivation from a preexisting protein.
Thus, in many practical circumstances, we must depend on an operational definition of a naturatoxin. Such a definition is that a naturatoxin is a toxic protein isolated by rupture, extraction, or after natural escape from microorganisms by laboratory manipulations presumed not to change the structure of the protein.
It is on occasion desirable to speak of a toxin which is partially active without reference to its relationship as a parent or derivative toxic material. In the case, e.g., of a toxin existing in a state in which its full potential for poisoning is not expressed, the term "demitoxin," suggested by Bonventre (6) , fits the need. If it is necessary to have a word as the counterpart to demitoxin, we suggest "teleotoxin," meaning the completely active toxin. Teleo is derived from the Greek teleo, teleos, or teleio, meaning "complete" or "perfect."
In the case of the botulinal toxins, it is the highmolecular-weight forms which, so far as we can tell, are the natural and progenitor materials from which other sizes and states of botulinal toxin have been prepared by laboratory manipulations. The high-molecular-weight material is isolated by extraction from the bacilli (28) and occurs as the exotoxin in culture media (42) .
One might argue that study of toxin from laboratory culture media is not equivalent to study of material occurring in nature. This is an unrealistic philosophical splitting of hairs. In any case, Sakaguchi, Sakaguchi, and Karashimada (40) have shown the high-molecular-weight (S20, 11.6 ) type E toxin to be produced by C. botulinum in food products in Japan. The evidence at hand and reason both lead us to conclude that high-molecular-weight botulinal toxins occur naturally, and it is logical to refer to them as naturatoxins. They are the progenitors of smallersized toxins which have been prepared in the laboratory. Thus, the smaller-sized toxins are derivative toxins and, unless they can be shown to occur in cultures, should not be considered to be naturatoxins.
In understanding toxins from the vantage point of their biological activity as poisons under natural circumstances, it is the form of the toxin to which the host is exposed that is important. Clinical and pharmacological interest should focus on the toxic material to which the victim of poisoning is exposed in real life, the naturatoxin. To learn what happens to that toxin in the body and the consequences that follow constitute necessary objectives of medical studies. If, in the laboratory, a toxin can be shown to have activity in different states of molecular shape and size, these findings are significant in exploring pathogenesis to the extent that these states can also be shown to be derivable within the body from the progenitor naturatoxin. In the cases of oral and parenteral exposure of laboratory animals to the types A (23, 24) and E (29) progenitor toxins, the result is the appearance in vivo of smallersized derivative toxins. Nonetheless, the effects of injection of derivative toxin into a susceptible host cannot be expected to be identical to the case of exposure to its progenitor naturatoxin. This has been clearly shown in a comparison of the 900,000-molecular weight crystalline A toxin with the 128,000-molecular weight derivative toxin. For the same intraperitoneal LD50 dose, the larger progenitor naturatoxin took longer than the smaller derivative toxin to kill mice when these toxins were injected intraperitoneally or intravenously (32) . Such a finding clearly indicates an inability of the larger molecule to rapidly or completely convert to the smaller-sized state under natural conditions in the body.
The same situation was not found with type E toxin. For the same intraperitoneal LD50 dose, trypsin-activated toxin injected intravenously kills more slowly than nonactivated toxin, irrespective of whether the S20w 11.6 or 7.3 toxins are employed. On the other hand, the larger-sized S20, 11.6 progenitor toxin and the smaller-sized S20o 7.3 activated derivative toxin kill mice injected intravenously with no difference in time of death (41) .
With type E, a larger dose in terms of intraperitoneal LD50 is required for oral poisoning by trypsin-activated toxin than for the parent, nonactivated naturatoxin (18; Sakaguchi, unpublished data). However, the oral lethal doses are on the same level in terms of weight of protein material (Sakaguchi, unpublished data) . The latter fact and other work (35) point to in vivo activation of the progenitor naturatoxin by exposure to enzyme within the alimentary tract.
Derivative type E toxin is not potent as an oral poison, since huge amounts are required to kill a mouse by ingestion (Sakaguchi, unpublished data); the doses of derivative toxin, whether trypsin-activated or not, are so large as to make it unlikely that botulism would ever occur by their ingestion as part of naturally contaminated food products. The nontoxicity of type E derivative toxin, when fed orally, was predictable from the finding that this material, unlike the progenitor toxin, is extremely labile to acid below pH 4 (29) .
In the nomenclatural scheme of Bonventre et al. (8) , no provision was made for the existence of simple toxins which naturally occur as complexes or aggregates of separate toxic and atoxic simple proteins. The term "syntoxin" does not cover this situation. The syntoxin, an example of which is anthrax toxin, is a multicomponent particle the individual components of which must act together in a complex to induce the property of toxicity (8 Type E toxin is subject to both enhancement and trypsin-induced quantitative activation. The trypsin activation has not been shown to rest on a reduction in the number of amino acid residues in the toxin molecule. Both the type E naturatoxin and the derivative toxin separated from the naturatoxin progenitor are subject to quantitative activation by trypsin.
